Migraine.AI
Migraine.AI offers personalized migraine management through a passive monitoring tool designed to predict triggers and optimize medication timing. The company's core offering is a mobile application that puts this management capability into the user's pocket. Led by a founder with experience in wearable technology and medical hardware, and supported by a scientific advisor from Oxford University and MIT, Migraine.AI aims to help users conquer migraines with a simple, button-touch interface. They are currently seeking beta users for their platform.
Migraine.AI
Migraine.AI offers personalized migraine management through a passive monitoring tool designed to predict triggers and optimize medication timing. The company's core offering is a mobile application that puts this management capability into the user's pocket. Led by a founder with experience in wearable technology and medical hardware, and supported by a scientific advisor from Oxford University and MIT, Migraine.AI aims to help users conquer migraines with a simple, button-touch interface. They are currently seeking beta users for their platform.
TL;DR
Product: Personalized migraine-management mobile app using passive monitoring and AI
Founding year & HQ: Founded 2018; Menlo Park, California
Founders: Ozcan Cikmaz (Founder/CEO), Aris Theophilakis (Co‑founder/CMO)
Funding: Seed round announced Nov 20, 2019; amount undisclosed
Company Overview
Problem Domain
Migraine management and digital health
Founded
2018
Industry
Digital health
Funding Track Record
Seed round announced Nov 20, 2019; amount undisclosed. Publicly listed participants include Newton Howard, Masashi Kiyomine, Richard Socher, David Lee, Sequoia Capital, Ali Tinazli.
Investor Signal
“Seed investors include named angels and firms (Newton Howard; Masashi Kiyomine; Richard Socher; David Lee; Sequoia Capital; Ali Tinazli).”